Please answer the questions below and click submit.

You will then be directed to the Cole Eye Institute Retina Summit video page.

1. Which of the following is the most common method of treating exudative AMD?
a. Treat and extend b. PRN c. Monthly treatment d. Three loading doses and then bimonthly treatment thereafter
2. Universal screening is currently mandated in all of the following situations:
a. All newborns >37 weeks gestational age b. Newborns between 34 and 37 weeks gestational age c. Newborns < 34 weeks gestational age d. None of the above
3. Ultra-Widefield Angiography is beneficial in which of the following situations:
a. Educating patients who have a rhegmatogenous retinal detachment b. Documenting whether or not macula is attached in patients with rhegmatogenous detachment c. Identifying areas of peripheral neovascularization with Ultra-WideField Angiography d. All of the above
4. Benefits of new generations of vitrectomy machines include:
a. Higher cut rates which potentially reduces peripheral traction b. Improved elimination for better visualization c. Smaller form factor for greater ease of use in surgery center d. All of the above
5. Which of the following is not a recent, novel innovation in vitro-retinal surgical instrumentation?
a. 27 gauge vitrectomy b. Intraoperative OCT c. Scleral buckling d. All of the above
6. Drugs in the pipeline for diabetes:
a. Kallikerin pathway b. Integrin inhibitor c. Tie/Ang pathway d. VAP-1 e. All of the above
7. Long acting drug delivery can be administered by all of the following except:
a. Drops b. Micropumps c. Lontopheresis d. Contact lenses
8. Benefits of heads up surgical display include:
a. Better posture b. Real time retinal display c. 3D viewing d. A and C e. None of the above